Latest filing published 17 Mar 2026 for Dermata Therapeutics, Inc., €1,072.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Munera Maria E. Bedoya-Toro: trading record in brief
Munera Maria E. Bedoya-Toro (chief executive) discloses dealings in Dermata Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 17 August 2021 to 17 February 2026, the count stands at 6 filings.
No open-market sale appears; the market trades are 1 purchase worth €1,072. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 1 purchase and no sales.
The record was last updated on 17 March 2026 with an open-market purchase (€1,072) in Dermata Therapeutics, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Munera Maria E. Bedoya-Toro
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$1.27100.0% of flowCommon StockSEC:0001493152-26-010630:0Canonical exit: 18 May 2026 (T+90)
- 9,162 sharesCommon StockSEC:0000905718-21-001112:0
2 of 2 declarations